Board Meeting-Appointment of Director
Outcome27-04-2018
Compliance Certificate For The Period Ended 31.03.2018
compliance certificate for the period ended 31.03.201825-04-2018
Shareholding for the Period Ended March 31, 2018
Ortin Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here21-04-2018
Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MURALI KRISHNA MURTHY SANKA Designation :- Director18-04-2018
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Change in Registered Office of the company from D. No: 1-2-593/29, Ground Floor, Street No.4, Gagan Mahal Colony, Near Bala Sai Temple, Domalguda Hyderabad - 500029 , Telangana to D. No: 3-4-512/35 (43/4RT), Barkatpura, Hyderabad - 500 027, Telangana22-02-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Extract of Un-audited results for the quarter ended 31.12.2017, published16-02-2018
Financial Results For The Quarter Ended 31.12.2017
Financial results for the quarter ended 31.12.201713-02-2018
Financial Results For The Quarter Ended 31.12.2017
Financial results for the quarter ended 31.12.201713-02-2018
Closure of Trading Window
The trading window in respect of the Company's Securities shall remain closed for all the Directors/Officers/Designated Employees of the Company from the trading hours on 01.02.2018 till 15.02.2018 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company for declaration of un-audited financial results for the quarter ended 31.12.2017.31-01-2018